- Did you mean
- patient reference
Search results - 10 results
Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme.
divergent results in the Belgian SARS-CoV-2 serology external quality assessment scheme. Sample IS /17575 was serum originating from a 30 years old male patient. 124 diagnostic laboratories analysed this ...
Citizens’ perception of and engagement with health data secondary use and sharing in Europe – a literature review
secondary use and sharing of health data. Citizens’ role and involvement Our review highlights the relative novelty of perceiving the citizen-patient as a key actor of the governance of health data secondary ...
End-of-life communication in advanced cancer: international trends (2009-2014).
options for end-of-life care (from 73% to 90%) in BE, and in GP s’ awareness of patients’ preferences for medical treatment and a proxy decision-maker in BE (from 41% and 20% up to 53% and 28%) and the NL ...
End-of-life care for people dying with dementia in general practice in Belgium, Italy and Spain: A cross-sectional, retrospective study.
dementia. Patient preferences for end-of-life care were known in a minority of cases. Few people (13-15 %) were transferred between care settings in the last week of life. CONCLUSIONS: Although overall ...
Hospitalisations at the end of life in four European countries: a population-based study via epidemiological surveillance networks.
(1.10 to 6.18); Spain: 4.72 (1.64 to 13.57); non-significant in Italy) and less likely if the GP knew the patient’s preferred place of death (OR s and 95% CI s Belgium: 0.52 (0.36 to 0.74); the ...
World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer.
conization Cryosurgery Cryotherapy Early Detection of Cancer Female Humans Neoplasm Staging Patient Preference Randomized Controlled Trials as Topic Uterine Cervical Neoplasms World Health Organization ...
End-of-life decisions: a cross-national study of treatment preference discussions and surrogate decision-maker appointments
differences and country-specific associated patient and care factors. RESULTS: GP-patient discussion of treatment preferences occurred for 10%, 7%, 25% and 47% of Italian, Spanish, Belgian and of Dutch patients ...
End-of-life medical treatment preference discussions and surrogate decision-maker appointments: evidence from Italy, Spain, Belgium and the Netherlands
associated patient and care factors, were examined using logistic regressions. RESULTS: 4396 non-sudden deaths were included. GP-patient discussion of treatment preferences occurred for 10%, 7%, 25% and 47% of ...
Awareness of general practitioners concerning cancer patients' preferences for place of death: Evidence from four European countries
RESULTS: The main study sample included 930 deceased cancer patients: preference for place of death was known by GP s for only 377. GP awareness on the preferred place of death varied across countries, 27% ...
Changing preferences for information and participation in the last phase of life: a longitudinal study among newly diagnosed advanced lung cancer patients
Abstract: PURPOSE: The objective is to explore changes over time in the information and participation preferences of newly diagnosed stage III b/ IV non-small-cell lung cancer patients. METHODS: Patients were ...